Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical device reporting: another final rule, Part II.

M Donawa1

  • 1Donawa and Associates Ltd, Rome, Italy. donawa@srd.it www.donawa.com

Medical Device Technology
|August 18, 2000
PubMed
Summary

This article details the final rule for US Medical Device Reporting (MDR) regulations, building upon previous discussions of MDR chronology and reporting responsibilities for international manufacturers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Center for Devices and Radiological health: an update.

Medical device technology·2005
Same author

Notified Body guidance on clinical evaluation.

Medical device technology·2004
Same author

Drug delivery systems: avoiding the pitfalls.

Medical device technology·2004
Same author

New FDA guidance on electronic records and signatures.

Medical device technology·2003
Same author

Update on the European database.

Medical device technology·2003
Same author

An important step forward in the global harmonisation of premarket review programmes.

Medical device technology·2003

Area of Science:

  • Regulatory Affairs
  • Medical Device Compliance

Background:

  • The US Medical Device Reporting (MDR) regulations have undergone significant changes.
  • Previous discussions covered MDR chronology and non-US manufacturer reporting.
  • The Designated Agent requirements were suspended.

Purpose of the Study:

  • To analyze the content of the recently published final rule for US Medical Device Reporting (MDR) regulations.
  • To provide clarity on updated MDR requirements for medical device manufacturers.
  • To inform stakeholders about the implications of the new MDR final rule.

Main Methods:

  • Review and analysis of the official US Medical Device Reporting final rule document.
  • Comparison of the final rule with previous MDR regulations and guidance.
  • Synthesis of key changes and requirements outlined in the final rule.

Main Results:

  • The final rule introduces specific updates and clarifications to the MDR framework.
  • Key provisions address reporting obligations, timelines, and definitions.
  • Non-US manufacturers will find updated guidance on compliance.

Conclusions:

  • Understanding the MDR final rule is crucial for ensuring continued compliance with US FDA regulations.
  • Manufacturers must adapt their reporting processes to align with the new requirements.
  • The final rule aims to enhance post-market surveillance and patient safety.

Related Experiment Videos